Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
暂无分享,去创建一个
J. Baselga | J. Seoane | M. Carducci | L. Paz-Ares | I. Braña | S. Estrem | M. Holdhoff | J. Blakeley | A. Cleverly | E. Calvo | D. Desaiah | I. Gueorguieva | M. Lahn | A. Azaro | J. Sepúlveda-Sánchez | E. Sicart | J. Rodón | N. Pillay